Phase I safety and immunogenicity study of NY-ESO-1b peptide and Montanide ISA-51 vaccination of patients with ovarian cancer (OC) in high risk first remission Meeting Abstract
| Authors: | Diefenbach, C. S. M.; Sabbatini, P.; Aghajanian, C.; Spriggs, D.; Lee, H.; Pezzulli, S.; Jungbluth, A. A.; Old, L. J.; Gnjatic, S.; Dupont, J. |
| Abstract Title: | Phase I safety and immunogenicity study of NY-ESO-1b peptide and Montanide ISA-51 vaccination of patients with ovarian cancer (OC) in high risk first remission |
| Meeting Title: | 42nd Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 24 |
| Issue: | 18 Suppl. Pt. 1 |
| Meeting Dates: | 2006 Jun 2-6 |
| Meeting Location: | Atlanta, GA |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2006-06-01 |
| Start Page: | 275S |
| Language: | English |
| ACCESSION: | WOS:000239009401532 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2006.24.18_suppl.5078 |
| Notes: | --- - Meeting Abstract: 5078 - 42nd Annual Meeting of the American-Society-of-Clinical-Oncology - JUN 02-06, 2006 - Atlanta, GA - S - Part 1 - "Source: Wos" |
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
